Meet with… Early Stage Investors | Multiple tracks for partnering

Add this event to your calendar:
30/09/2015 12:30 30/09/2015 14:30 America/Chicago Meet with… Early Stage Investors | Multiple tracks for partnering Texas Medical Center , John P. McGovern Campus , Houston , TX 77021 JLABS @ TMC false DD/MM/YYYY

Meet with… Early Stage Investors | Multiple tracks for partnering

Texas Medical Center , John P. McGovern Campus , Houston , TX 77021

September 30, 2015 from 12:30 PM to 14:30 PM (CST)

$10 - $35

JLABS TEXAS EVENT JLABS @TMC has taken a Texas sized approach to our JLABS' Meet with... Series by bringing three early stage investors to Houston for one-on-one meetings with emerging healthcare companies. The firms, including Allegory Ventures, Azimuth Ventures and Johnson & Johnson Innovation - JJDC, represent corporate, angel and traditional venture models hailing from California, Texas and New York. The speakers will participate in a series of presentations led by the Houston Angel Network and discuss their firms' key areas of interest, trends and best practices when seeking funding.

Following the presentation, don't miss this opportunity to network with fellow attendees and the panelists during lunch. Finally, for those companies who apply online and receive approval, Allegory, Azimuth, and JJDC will be on hand to meet one-on-one with selected applicants.

10:30 AM | Registration Opens, Networking session
11:00 AM | Presentation and Q&A
11:50 AM | Networking Lunch
12:30 PM | One-on-one Meetings*
5:00 PM | Program Close

*Companies must apply for a one-on-one meeting ahead of time and be approved. The application period ends on September 5th.

Participating Representatives:
Thomas DeSouza | Managing Partner, Allegory Venture Partners read bio»
Renee Compton Ryan | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC read bio»
Robert Tucci | Head, Life Sciences Group, Houston Angel Network [Moderator] read bio» 

About Allegory Venture Partners:
Allegory Ventures Partners (Allegory) is life sciences focused venture capital firm based in Houston, Texas and Portland, Oregon. Funded through a collaboration with Oregon Health Science University (OHSU), Allegory receives financial support from the University, as well as opportunity to examine new technologies arising from OHSU research programs which are catalyzed by the recent $1B Knight Challenge. Allegory Ventures is interested in meeting digital health/health IT, healthcare services, medical devices and diagnostics and research tools and technologies. (apply here)
Thomas DeSouza Allegory's Participating Representative: Thomas DeSouza | Managing Partner, Allegory Venture Partners
Thomas has been working with entrepreneurs and allocating capital to promising companies for over a decade. Having founded multiple start-ups and working with management of many exciting young companies, Thomas is no stranger to the issues that early stage companies face. Prior to Allegory, Thomas was a partner of the DeSouza Perez Group at Robert W. Baird & Co. He joined Baird after his time at Morgan Stanley as a Portfolio Manager. Thomas is a Board Director of SemanticMD. Thomas attended Portland State University with degrees in Finance and Political Science. He has been responsible for the development of two non-profit organizations within the last six years. He is an active member in the Keiretsu forum where he is a member of the life sciences sub-committee. Thomas also serves on the Board of Directors and Investment Committee for Willamette View Foundation.
Connect with Thomas: Connect on LinkedIn Connect on Twitter

About Johnson & Johnson Innovation - JJDC:
As the oldest corporate venture fund in the life science industry, Johnson & Johnson Innovation - JJDC has been making strategic investments in life science innovations for over 40 years. JJDC has invested and funded hundreds of emerging life science companies developing health care solutions in the areas of strategic interest to the Johnson & Johnson Family of Companies and plays a key role in the company's strategy to bring new healthcare products to the people who need them. JJDC is interested in meeting medical device and consumer medical device companies. (apply here)
Renee Ryan JJDC's Participating Representative: Renee Compton Ryan | Vice President, Venture Investments, Johnson & Johnson Innovation - JJDC
Renee Compton Ryan joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California and primarily supports the strategic investment activities in medical devices and diagnostics. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co. Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.
Connect with Renee: Connect on LinkedIn Connect on Twitter

Moderator's Biography:
Rob Tucci Robert Tucci | Head, Life Sciences Group, Houston Angel Network
Rob Tucci is an active investor and nine year member of the Houston Angel Network where he is Head of the Life Sciences Group. He is a member of the University of Houston's Cougar Fund, serving as a judge and has lectured in the Bauer School of Business. At the $4 M Texas Halo Fund, Rob serves on the managing Board of Directors and directs investments generally within the biotechnology, life sciences and energy sectors. He is the founder of Yardley Group, LLC, an active international chemical development and export business. Rob serves as a judge at the Rice University Business Plan Competition, the world's largest. He has been an investment adviser to the University of Texas Horizon Fund, the National Space Biomedical Research Institute, and co-founder of Houston Health Ventures. Rob is active on the Board of Directors of Adient Medical, Inc and other companies. A chemist and MBA, Rob lives in Houston with his physician wife.
Connect with Rob: Connect on LinkedIn Connect on Twitter

Presentation & Lunch
$25 | General Public
$35 | General Public - at the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until September 29th (or full).

One-on-One Meeting
FREE | Application
FREE | Accepted Companies
Companies must apply for a one-on-one meeting ahead of time. The one-on-one application period ends on September 5th. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. All companies accepted for a one-on-one meeting will be notified of acceptance and scheduled meeting time via email.

About the Meet with... Series:
The purpose of the Meet with Series events sponsored by JLABS is to help start-up entrepreneurs, as well as the academic community, connect with potential partners, such as big pharma or other investment corporations, through one-on-one meetings. It is also a chance for the featured corporation to outline their specific business development goals and clarify what types of products or research they are interested in and how best to approach them to get the partnering process started. Past participants include the Wellcome Trust, Bill & Melinda Gates Foundation, MedImmune Ventures, NCI, Mercury Fund, DARPA's Biological Technologies Office, Correlation Ventures, Breakout Labs, New Enterprise Associates, Canaan Partners, Thomas McNerney & Partners, NCATS, NINDS, Johnson & Johnson Innovation, Poliwogg, California Institute for Regenerative Medicine, Astellas Venture Management, and OrbiMed.

Texas Medical Center
John P. McGovern Campus
2450 Holcombe Blvd, Suite X
Houston, TX 77021

Parking Information:
Please park in the self parking areas of the McGovern Campus. Grab a Token at the gate and bring it to the event space. We encourage carpooling and using the TMC shuttles.


Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit

Event contact

Related content